Emcure Pharma Slips as Bain Capital Prepares Partial Stake Exit

e Pharmaceuticals traded nearly 3% lower today, reflecting investor caution as BC Investments IV—an affiliate of Bain Capital—prepares to offload up to a 2% stake through large block deals. The proposed transaction is valued at ₹493 crore, with a floor price set at ₹1,296.5 per share, according to reports. As of September 2025, BC Investments held 6.3% in the company, making this a noteworthy reduction. While such stake sales are routine for long-term private equity investors, the sizable deal has weighed on sentiment. The decline suggests the market is factoring in supply pressure, though the development may also attract new institutional buyers.